Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
- PMID: 16741317
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Comment in
-
18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology.J Nucl Med. 2006 Jun;47(6):901-3. J Nucl Med. 2006. PMID: 16741296 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical